Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA Management Board: highlights of December 2016 meeting 19 December 2016Press releaseCorporate EMA website briefly unavailable on 20 December 19 December 2016NewsCorporate Tailored scientific advice to support step-by-step development of new biosimilars 16 December 2016NewsHumanBiosimilars New oral treatment for rheumatoid arthritis 16 December 2016Press releaseHuman Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B 16 December 2016Press releaseHuman Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016 16 December 2016NewsHuman EMA hosts workshop on adaptive pathways 13 December 2016Press releaseCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting 6-8 December 2016 9 December 2016Press releaseVeterinary EMA website briefly unavailable on 9 December 8 December 2016NewsCorporate PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C 2 December 2016Press releaseHumanPharmacovigilance 1 … 143 144 145 146 147 Page 147 of 380 148 149 150 151 … 380
Tailored scientific advice to support step-by-step development of new biosimilars 16 December 2016NewsHumanBiosimilars
Direct-acting antivirals for hepatitis C: EMA confirms recommendation to screen for hepatitis B 16 December 2016Press releaseHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2016 16 December 2016NewsHuman
Committee for Medicinal Products for Veterinary Use (CVMP) meeting 6-8 December 2016 9 December 2016Press releaseVeterinary
PRAC warns of risk of hepatitis B re-activation with direct-acting antivirals for hepatitis C 2 December 2016Press releaseHumanPharmacovigilance